BioMarin Pharmaceutical, Inc. (BMRN)
64.84
-0.39
(-0.60%)
USD |
NASDAQ |
Sep 01, 16:00
64.88
+0.04
(+0.06%)
After-Hours: 20:00
BioMarin Pharmaceutical Net Income (TTM) : 72.97M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.97M |
| March 31, 2026 | 268.74M |
| December 31, 2025 | 348.90M |
| September 30, 2025 | 520.42M |
| June 30, 2025 | 657.24M |
| March 31, 2025 | 523.88M |
| December 31, 2024 | 426.86M |
| September 30, 2024 | 322.29M |
| June 30, 2024 | 256.59M |
| March 31, 2024 | 205.46M |
| December 31, 2023 | 167.64M |
| September 30, 2023 | 147.02M |
| June 30, 2023 | 99.99M |
| March 31, 2023 | 71.62M |
| December 31, 2022 | 141.56M |
| September 30, 2022 | 83.91M |
| June 30, 2022 | 54.07M |
| March 31, 2022 | 39.35M |
| December 31, 2021 | -64.08M |
| September 30, 2021 | 15.92M |
| June 30, 2021 | 837.21M |
| March 31, 2021 | 795.09M |
| December 31, 2020 | 859.10M |
| September 30, 2020 | 852.02M |
| June 30, 2020 | 122.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 114.01M |
| December 31, 2019 | -23.85M |
| September 30, 2019 | -42.52M |
| June 30, 2019 | -110.18M |
| March 31, 2019 | -89.54M |
| December 31, 2018 | -77.21M |
| September 30, 2018 | -124.95M |
| June 30, 2018 | -124.86M |
| March 31, 2018 | -144.90M |
| December 31, 2017 | -117.04M |
| September 30, 2017 | -156.37M |
| June 30, 2017 | -181.27M |
| March 31, 2017 | -563.45M |
| December 31, 2016 | -630.21M |
| September 30, 2016 | -470.87M |
| June 30, 2016 | -524.37M |
| March 31, 2016 | -187.35M |
| December 31, 2015 | -171.80M |
| September 30, 2015 | -310.21M |
| June 30, 2015 | -211.84M |
| March 31, 2015 | -163.36M |
| December 31, 2014 | -133.97M |
| September 30, 2014 | -126.16M |
| June 30, 2014 | -186.63M |
| March 31, 2014 | -174.66M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Incyte Corp. | 1.612B |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| BridgeBio Pharma, Inc. | -702.02M |
| Ionis Pharmaceuticals, Inc. | -564.78M |